Stock Expert AI

Content generated by AI editorial engine. Editorially supervised by Sedat ANAK.

Equifax Inc.
EFX - NYSE - $175.83 (as of ) ▲ +0.12%
-
Earnings Tue 21 Jul
Note: this preview was published before the 2026-07-21 earnings report. Results have since been released — verify against the latest filings.

Equifax Inc. (EFX) Q2 FY26 earnings preview — archived, published May 9, 2026

The median of 2 price targets is $222[FMP target], stock is $176, +26.3% vs the analyst consensus median. Q1 FY26 EPS $1.86 vs $1.69 estimate: beat (+10.1%)[FMP earnings]. Stock move on D+1: -7.2%.

↓ summary below
Quick Take - in 40 seconds ·
B
Council 4/6 - Historical V1 score 47

B — FMP rating [FMP ratings]. Form 4: unavailable[FMP Form 4].

Quick Answer

Equifax Inc. (EFX) Q2 consensus: revenue $1.7B[FMP est], EPS $2.25[FMP est]. 5 consecutive quarters of beat[FMP earnings].

$2.25 EPS Estimate Last year $2.00 - +13% YoY
5 Beat Streak Expectations beaten consecutively for the last 5 quarters

Q1 FY26 EPS $1.86 vs $1.69 estimate: beat (+10.1%)[FMP]. Stock move on D+1: -7.2%[FMP D+1].

Watchlist

5 metrics stand out this quarter.

20% Investor Focus

Mortgage Revenue Growth

mortgage_revenue_growth

Despite a strong Q1, Equifax is maintaining its 2026 mortgage revenue growth guidance of over 20% due to uncertainty related to the Iran conflict.

"We are maintaining our 2026 guidance for mortgage revenue growth of over 20%, consistent with the framework we provided in February, as a stronger-than-expected first quarter mortgage revenue growth is offset by our expectation of current trends of slightly slower growth over the remainder of the year versus our February guide."

- Mark Begor, Chief Executive Officer - Q1 FY26 Earnings Call - April 21, 2026
75 Risk Indicator

Margin Expansion

margin_expansion

Equifax expects to deliver strong full-year margin expansion, excluding FICO, of 75 basis points from operating leverage of strong top-line growth, higher margin new products, and AI-driven productivity.

"We also expect to deliver strong full year margin expansion, excluding FICO of 75 basis points from operating leverage of strong top line growth, higher margin new products and AI-driven productivity."

- Mark Begor, Chief Executive Officer - Q1 FY26 Earnings Call - April 21, 2026
- Investor Focus

Government Revenue Growth

government_revenue_growth

Equifax remains energized about the mid- and long-term growth opportunities for EWS government at both the federal and the state level in meeting new federal requirements regarding accuracy of income validation in Medicaid and SNAP.

"We remain energized about the mid- and long-term growth opportunities for EWS government at both the federal and the state level in meeting new federal requirements regarding accuracy of income validation in Medicaid and SNAP as well as work, education and community engagement requirements and Medicaid benefits."

- Mark Begor, Chief Executive Officer - Q1 FY26 Earnings Call - April 21, 2026
- Investor Focus

TWN Indicator Growth

TWN_indicator_growth

Equifax is delivering TWN income and employment attributes at no cost to its customers to drive credit file share gains and future TWN VOI and VOE growth.

"And as a reminder, Equifax is delivering TWN income and employment attributes at no cost to our customers to drive credit file share gains in TWN VOI and VOE growth in the future."

- Mark Begor, Chief Executive Officer - Q1 FY26 Earnings Call - April 21, 2026
$327 Investor Focus

Capital Allocation

capital_allocation

Equifax has $1.5 billion of capital available in 2026 to invest in both bolt-on M&A and return of cash to shareholders, and returned $327 million to shareholders in Q1.

"In the first quarter, we returned $327 million to shareholders."

- Mark Begor, Chief Executive Officer - Q1 FY26 Earnings Call - April 21, 2026

Stock Expert AI - Methodology

Do our scoring pillars, 6 perspectives, and Munger lens point in the same direction?

Council Score 4 / 6 Bullish

6 investor frameworks. 4 bullish (Ray Dalio, Klarman, Buffett, Munger), 1 bearish (Ken Griffin), 1 neutral (Jim Simons).

How is it calculated? ->
Ray Dalio macro - target upside +26.3%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 46
Klarman value - target upside +26.3%
Buffett quality - ROE score 4/5
Munger valuation - target upside +26.3%
Munger's Mindset character & balance sheet lens
Undervalued

Quality business, discounted price.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyStrong
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
45.8 RSI 45.8 balanced, 50d below
MACD
-4.50 price below 50d - resistance dominant
50d MA
$184 stock 4.5% below - short-term resistance
200d MA
$215 stock 18.1% below - long-term pressure
Volume (10d)
-18% decrease - low participation
Resistance
$222
Analyst median target - upgrade trigger if broken
Current
$176
Pre-earnings position
Support
$182
Invalidation - close below this is a technical breakdown
Pattern
Range
$182-$222 band - earnings breakout/breakdown trigger

Past Performance

4 quarters shown.

BEAT
Q2 FY25
$2.00 vs $1.93 est · Next-day price move: +3.1%
BEAT
Q3 FY25
$2.04 vs $1.94 est · Next-day price move: +0.3%
BEAT
Q4 FY25
$2.09 vs $2.06 est · Next-day price move: +5.5%
BEAT
Q1 FY26
$1.86 vs $1.69 est · Next-day price move: -7.2%

Q1 FY26 (April 21, 2026) EPS $1.86 vs $1.69 estimate: beat (+10.1%)[FMP]. Stock move on D+1: -7.2%[FMP D+1].

Three scenarios: what could happen?

EPS < $2.18 (no guidance)

Q1 FY26 EPS $1.86 vs $1.69 estimate: beat (+10.1%)[FMP]. Stock move on D+1: -7.2%[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $120.4M[FMP cashflow]. Q1 op margin 17.4%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q2 EPS > $2.25 + CapEx discipline
Threshold: EPS > $2.25[FMP est].
Target: Break above median target $222[FMP target]; high target $265[FMP] upper bound.
Scenario B - In-Line
EPS approx $2.25 + CapEx < $120.4M
Threshold: EPS approx $2.25[FMP est], Q4 CapEx < $120.4M[FMP].
Target: Consolidation in the band between current $176[FMP] and median $222[FMP].
Scenario C - Miss
EPS < $2.18 or CapEx >= $120.4M
Threshold: EPS < $2.18[FMP estx0.97].
Current price $176 — below SMA200 $215 [FMP].

Market Outlook

What do analysts say? 2 price targets · 24 ratings

Wall Street Consensus
$222
12-month median target price (+26.3% gap to the analyst consensus median)
17
BUY
7
HOLD
0
SELL
Risk Management
$182
Invalidation level - critical support threshold
$184 - 50-day MA (below, -4.5%)
$215 - 200-day MA (below, -18.1%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - EFX Q2 FY26
B

You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Tuesday evening. The framework is ready on this page: Q2 EPS threshold $2.25[FMP], CapEx threshold "below $120.4M". Two anchors, three scenarios.

Comparison Stock Expert AI is free today — no credit card.

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI is free today — no credit card. Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 21, 2026EARNINGSQ2 FY26 results (after market close) + earnings call
Jul 22, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Aug 9, 2026 – Aug 14, 2026FILING10-Q due within 40–45 days of quarter end (by Aug 9, 2026 – Aug 14, 2026); the exact deadline depends on filer status
~Oct 21, 2026EARNINGSQ3 FY26 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the EFX Q2 FY26 earnings preview cover?

This Equifax Inc. (EFX) Q2 FY26 earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in EFX Q2 FY26 earnings?

Equifax Inc. (EFX): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.

Where do the numbers on this page come from?

Equifax Inc. (EFX): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.

Is this a buy or sell recommendation?

Equifax Inc. (EFX): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.

More earnings, decoded